drugset / Trial / NCT00767806

A Study for Patient With Chronic Low Back Pain

NCT00767806 ↗

Phase 3 Completed 401 enrolled Eli Lilly and Company
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if duloxetine reduces the severity of chronic low back pain.

Timeline

Start
2008-09
Primary completion
2009-07
Completion
2009-07

Outcome

Met primary endpoint

registry analysis (superiority or other test); Duloxetine vs Placebo; p = 0.001; Mixed Models Analysis NCT00767806 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral

Indications